Polycore Medical Technology (Shenzhen) (CONMIND)
Interventional medical devices for neurovascular and cardiac conditions
About Polycore Medical Technology (Shenzhen) (CONMIND)
Established in 2020 in Shenzhen, China, Polycore Medical Technology (CONMIND) specializes in the research, development, and production of advanced medical devices. The company focuses on integrated treatment for neurointervention and structural heart disease, providing solutions for cardiac and neurovascular conditions to healthcare professionals and patients globally.
CONMIND's product portfolio for neurointervention includes devices such as the J-Tube™ Flow Diverter Stent, Kapflex™ smart wall apposition device, Crassula™ for soft conformability, Campsis™ for delivery and reach, Thatch™ for flexible tip and firm support, and the Cycas™ and Fringe® devices. The company operates a CNAS-certified laboratory and advanced cleanroom facilities, holding over 200 patents. It began its first human clinical trial for the J-Tube™ Flow Diverter Stent in August 2022.
The company serves hospitals and its products have reached over 20 countries and regions. Its business model is centered on the innovation, manufacturing, and sales of its specialized medical devices. A facility in Zhuhai, built to international standards, supports the commercialization and mass production of its products to meet market growth.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 13.0/100
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Aug 2023 | $14M | $55M | Chengdu Chuanghe Ruixin · TriWise Capital · Turing Asset Management · Zhuhai Hi-Tech Financial Investment | ↗ |
Growth signals
Latest recorded traffic for Polycore Medical Technology (Shenzhen) (CONMIND) is 190 monthly website visits, down 60.4% over the last three months.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Polycore Medical Technology (Shenzhen) (CONMIND) in the Ningbo ecosystem
The Polycore Medical Technology (Shenzhen) (CONMIND) office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
- CRChengdu Chuanghe Ruixin
- TCTriWise Capital
- TMTuring Asset Management
- ZIZhuhai Hi-Tech Financial Investment
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Polycore Medical Technology (Shenzhen) (CONMIND) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Polycore Medical Technology (Shenzhen) (CONMIND)’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.